Compositions and methods of treatment for tinea pedis
AssigneeTherapeutics, Inc.
InventorWalter THOMPSON
Life of this patent
Estimating the term…
Abstract
Pharmaceutical compositions containing a synergistic combination of at least one antifungal active ingredient and at least one keratolytic agent and methods of treating tinea pedis with the pharmaceutical compositions are described. These pharmaceutical compositions include synergistic combinations of naftifine or terbinafine and urea, or naftifine or terbinafine and ammonium lactate, for effective treatment of moccasin-type and interdigital-type tinea pedis.
Claims21
A method for treating tinea pedis in a subject, the method comprising administering an effective amount of a pharmaceutical composition to a subject in need thereof, the composition comprising a synergistic combination of at least one antifungal active ingredient and at least one keratolytic agent,
- wherein the at least one antifungal active ingredient is selected from the group consisting of pharmaceutically acceptable forms of terbinafine, butenafine, amorolfine, clotrimazole, econazole, ketoconazole, miconazole, tioconazole, fluconazole, itraconazole, posaconazole, voriconazole, a pharmaceutically acceptable salt thereof, and a combination thereof, and
- wherein the at least one keratolytic agent is selected from the group consisting of urea, ammonium lactate, salicylic acid, podofilox, podophyllum resin, trichloroacetic acid, alpha-hydroxy acids, poly hydroxyl acids, lactic acid, allantoin, resorcinol, glycolic acid, and combinations thereof.
-21. (canceled)
Dependencies are inferred from the claim text.